Answers are grounded in this paper and cite their sources.
Cohort study shows the risk of postacute sequelae is low in boosted cancer patients, indicating importance of vaccination.
The findings of this cohort study suggest that among highly boosted patients with cancer, the overall risk of postacute sequelae following Omicron SARS-CoV-2 infection was not significantly elevated compared with noninfected patients; however, patients who were hospitalized for COVID-19 remained at increased risk of postacute sequelae despite administration of COVID-19 therapeutics. These findings further suggest that COVID-19 vaccination and boosting remain important in mitigating the risk of long COVID among immunocompromised patients during endemicity.
No takes yet. Share an insight, caveat, or question.
Wee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: